🔎 Trials Near Me

Dachaigh › Tùmail an eanchainn › Texas

Sgrùdaidhean clionaigeach Tùmail an eanchainn ann an Texas

Tha 42 sgrùdaidhean airson Tùmail an eanchainn a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

  • Baylor St. Luke's Medical Center, Houston
A’ fastadhÌre 1
Aoisean 21 gu 70 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06815432

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Baylor, Scott and White Research Institute, Dallas
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06047379

Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

  • Mays Cancer Center, UT Health San Antonio, San Antonio
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07470606

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

  • The University of Texas M. D. Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07053033

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05048212

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • MD Anderson Cancer Center, Houston
  • START San Antonio, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT05786924

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  • Local Institution - 0085, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07492680

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  • UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
  • Cook Children's Medical Center, Fort Worth
  • Texas Children's Hospital, Houston
A’ fastadhÌre 2
59 Months · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05535166

OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy

  • MD Anderson Cancer Center, Houston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07655583

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

  • M D Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04988009

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • NEXT Oncology - Austin, Austin
  • Mary Crowley Cancer Research, Dallas
  • MD Anderson Cancer Center - University of Texas, Houston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06253871

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

  • MD Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07467109

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • University of Texas MD Anderson Cancer Center, Houston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05386108

Targeted Pediatric High-Grade Glioma Therapy

  • Texas Children's Hospital, Houston
A’ fastadhSgrùdadh amharc
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

  • UT MD Anderson Cancer Center, Houston
  • UT Health San Antonio Mays Cancer Center, San Antonio
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07428616

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

  • MD Anderson Cancer Center, Houston
A’ fastadhÌre 1
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

  • Texas Children's Hospital, Houston
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

  • MD Anderson Cancer Center, Houston
  • Community Clinical Trials, Kingwood
  • Tranquil Clinical Research, Webster
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06764940

Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)

  • Ut Southwestern Medical Center, Dallas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07139990

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

  • Mary Crowley Cancer Research, Dallas
  • The University of Texas M.D. Anderson Cancer Center, Houston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06136884

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

  • Houston Methodist Neal Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07383649

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

  • Excel Diagnostics & Nuclear Oncology Center, Houston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

  • Texas Children's Hospital, Houston
A’ fastadhÌre 1
12 Months – 25 Years · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT04099797

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

  • UT Southwestern Simmons Cancer Center, Dallas
  • Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
  • Houston Methodist Hospital, Houston
  • agus 2 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT04427384

Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 1
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT03830151

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT05673928

Mapping of Human Cognition

  • The University of Texas Health Science Center at Houston, Houston
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Iuch 2026 · NCT05989893

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Texas Children's Hospital, Houston
A’ fastadhÌre 2
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

  • M D Anderson Cancer Center, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT02754544

A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain

  • M D Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT05342454

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT05064280

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • MD Anderson Cancer Center, Houston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06810544

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

  • Md Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT04075305

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

  • M D Anderson Cancer Center, Houston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Gearr 2026 · NCT05700721

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Elligo Health Research, Inc., Austin
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT05366881

Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors

  • MD Anderson Cancer Center, Houston
A’ fastadh
Aoisean 15 gu 39 · Gach gnè · Air ùrachadh 9 Faoi 2026 · NCT06799481

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Dàmh 2025 · NCT03418961

Systematic Light Exposure in Pediatric Brain Tumor Survivors

  • Texas Children's Hospital, Houston
A’ fastadh
Aoisean 10 gu 18 · Gach gnè · Air ùrachadh 18 Sult 2025 · NCT05340881

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

  • MD Anderson, Houston
  • NEXT Oncology, San Antonio
A’ fastadhÌre 1/2
Aoisean 18 gu 89 · Gach gnè · Air ùrachadh 19 Lùna 2025 · NCT06907043

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.